Non-treatment

OTHER3 trials

Sponsors

Medicis Global Service Corporation, University of Southern California

Conditions

Cervical Prostaglandin EP3 ReceptorsFacial VolumeLip AugmentationPregnancy

Unknown Phase

Safety/Efficacy Study of Restylane® in Lip Augmentation

CompletedNCT00935272

Medicis Global Service CorporationLip Augmentation

Start: 2009-07-31End: 2010-07-31Updated: 2012-01-30

The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors

TerminatedNCT01224509

University of Southern CaliforniaCervical Prostaglandin EP3 Receptors, Pregnancy

Start: 2004-09-30End: 2005-03-31Updated: 2010-10-20

Efficacy and Safety of Perlane-L in the Correction of Midface Volume Deficit

Medicis Global Service CorporationFacial Volume

Start: 2012-03-31End: 2013-12-31Updated: 2013-08-21